Author(s): Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T
Abstract Share this page
Abstract The authors reviewed the clinical features and outcome of Miller Fisher syndrome (MFS) for 50 consecutive patients with MFS including 28 patients who received no immunotherapy. Besides the characteristic clinical triad (ophthalmoplegia, ataxia, and areflexia), pupillary abnormalities, blepharoptosis, and facial palsy are frequent in MFS, whereas sensory loss is unusual despite the presence of profound ataxia. Patients with MFS usually had good recovery and no residual deficits.
This article was published in Neurology
and referenced in Journal of Addiction Research & Therapy